‘Wearables’ doesn’t just mean Fitbits and smart watches anymore. The term encompasses a whole bunch of cutting-edge technologies that are making real-time medical monitoring and treatment more effective and comfortable than ever. But some developments are more sci-fi and surprising than others.
Innovation in sensor technology is transforming the world of wearable IVDs and medical devices. Strides in miniaturisation, IoT and AI are making real-time tracking, diagnosis and treatment possible in ways that were unimaginable just a few years ago.
'Smart clothes' and headsets, single-use patches and other appendages are among a host of innovations that are being made possible by smaller, thinner and more capable MEMS and MOEMS.
MEMS are the sensors that measure physical properties or chemical changes within their surrounding environment, such as temperature, acceleration and pressure. MOEMS are Micro-Opto-Electro-Mechanical Systems, that use optics for imaging, measurement and actuation.
Common types of sensors include accelerometers, pressure gauges (which measure force), flow meters (which measure fluid flow), and gyroscopes (which measure angular velocity).
This technology is getting smaller than ever. MEMS can range in size from several mm to an impossibly small size: less than 1 micrometre or 1000 of a millimetre. At this size, it is not even visible to the human eye.
At the same time, the use of new materials, coatings and finishes ensure they are becoming safer and more comfortable for use in intimate, bodily settings. What’s more, their extraordinary sensitivity and capacity for data capture and actuation continues to grow.
Sensors used to measure and track specific bodily functions like muscle and brain activity include Electromyographic (EMG) and Electroencephalographic (EEG) based MEMs.
Meanwhile, cMUTs (Capacitive micromachined ultrasonic transducers) are paving the way for wearables that can transmit images of organs and even the inside of veins and blood vessels.
Next-generation ultrasound transducers are being developed by researchers in Canada that can be integrated into adhesive patches the size of postage stamps. Their potential for ‘mass-fabrication and versatile integration’ will make preventive, real-time medical monitoring for otherwise invisible conditions easier and cheaper than ever before.
Here are 8 of the most eye-opening, sensor-driven wearable medical devices that we’ve seen in development and in the market over the last few years:
Inviza, a startup based in the United States, has created innovative tracking insoles designed for remote patient monitoring. These insoles seamlessly integrate into footwear and establish automatic connections with smartphones. Individuals can access real-time fitness and location biometric analytics by wearing these insoles while walking, skipping, or running.
H-Cube, an Italian startup, has developed an advanced product called H-Tee, specifically designed for athletes. This smart t-shirt incorporates cutting-edge technology, including contactless electrodes and batteries, to extract various vital signs such as cardiac variability, heart rate, body temperature, blood pressure, and respiratory rate.
ABIORO, a Brazilian startup, is focused on revolutionising cardiac event monitoring with its Abioro RX Patch. This wearable patch is a practical alternative to traditional holter monitors, delivering an ergonomic and comfortable experience. By leveraging bio-sensing and deep learning technologies, the Abioro RX Patch accurately diagnoses cardiac arrhythmia, providing doctors with reliable data for remote patient monitoring.
EMOTIV is a company developing EEG (Electroencephalogram) tech for business and medical use. Using sensors integrated into headsets, the technology gathers information about an individual's brain activity for insight into emotional states and cognitive responses triggered by external stimuli. Headsets are sold to academic researchers and even marketers who want insight into consumer reactions to products and adverts:
EMOTIV’s portable EEG headsets measure brainwaves with millisecond accuracy — providing real insights into how someone feels about your products or media.”
The technology is currently being explored for its potential to help those with neurodegenerative diseases control devices and communicate through apps by the power of their thoughts alone.
Imago Rehab has developed a soft robotic glove to support medical rehabilitation in stroke patients. It incorporates sensors to help patients exercise weak limbs properly, with MEMs being used to monitor and support delicate muscle responses:
To make the glove comfortable and natural feeling to wearers, the actuators powering the movements of the glove were made smaller and modified over several iterations of design to distribute forces more evenly over the wearer’s fingers and thumb.”
IoT ensures data about improvements in muscle performance can be relayed in real-time to physios, who can then make remote adjustments to exercise regimes via the gloves.
Medtronic have developed their MiniMed™ 780G System, as the next phase in their artificial pancreas development for Type 1 Diabetics. The hybrid closed loop (HCL) system uses biosensor patches to keep track of glucose levels and actuates insulin delivery as required. The design incorporates meal detection technology that automatically adjusts and corrects sugar levels every 5 minutes.
DFree is developing support products for urinary incontinence. It uses a non-invasive sensor attached to patients’ bodies to support incontinence management around the clock. The product uses ultrasound technology to detect when the bladder is full and notify patients, via an app, when they need to urinate.
A team at the University of California in San Diego, has pioneered a single, wireless ultrasound adhesive patch that can monitor blood pressure, heart health, and lung capacity in real time:
The credit-card-size ultrasound patch can monitor signals from tissues as deep as 16 centimeters under the skin. It can continuously measure blood pressure, heart output, respiratory health, and other physiological signals for up to 12 hours on a single charge.
Researchers and entrepreneurs are exploring new possibilities for wearable medical devices. But commercial, regulatory and practical pressures can easily stop novel ideas from being realised.
Dealing with the complexities of building devices that are comfortable, efficacious and viable is one thing. Meeting all the FDA requirements for testing and proving the safety of ‘novel’ medical products is another. Moving from ideation to development can take more than 7 years, clinical trials can take between 1 - 3 years, while PMA approval from the FDA for bleeding edge devices can take more than 3 years to achieve.
Don’t forget Apple’s iWatch was released with huge fanfare in 2015, and was hailed for its potential to transform preventive medicine, but it was not then approved as ‘a medical device’ by the FDA. The leap from a fitness or wellbeing device, to a medical grade diagnostic tool is a huge one.
Companies wanting to bring their wearable innovation to a medical market will need to ensure their devices are built to the highest possible safety standards, while remaining commercially viable.
To achieve this, designers and developers need to collaborate with manufacturers who have the experience and facilities to deliver at scale in the medical device sector. They will need access to complex supply chains, specialist components and highly skilled labour. They’ll need to ensure the microscopic MEMs and MOEMs they require are produced to exacting FDA standards but can still be manufactured at the required scale.
Many will need to value engineer their approach and apply DFX (Design for Excellence) techniques to achieve the dream of wearable medical devices for all.